Post-Capillary Pulmonary Hypertension: Clinical Review

被引:0
|
作者
Riley, Joshua M. [1 ]
Fradin, James J. [2 ]
Russ, Douglas H. [1 ]
Warner, Eric D. [1 ]
Brailovsky, Yevgeniy [3 ]
Rajapreyar, Indranee [3 ]
机构
[1] Thomas Jefferson Univ Hosp, Dept Med, Philadelphia, PA 19147 USA
[2] Thomas Jefferson Univ, Sidney Kimmel Med Coll, Philadelphia, PA 19147 USA
[3] Thomas Jefferson Univ Hosp, Jefferson Heart Inst, Philadelphia, PA 19147 USA
关键词
pulmonary hypertension; post-capillary; heart failure; advanced heart failure; HFrEF; PRESERVED EJECTION FRACTION; LEFT-VENTRICULAR DYSFUNCTION; HOSPITALIZED HEART-FAILURE; VASCULAR-RESISTANCE; WEDGE PRESSURE; DIASTOLIC DYSFUNCTION; EXERCISE CAPACITY; PROGNOSTIC VALUE; OUTCOMES; MORTALITY;
D O I
10.3390/jcm13020625
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Pulmonary hypertension (PH) caused by left heart disease, also known as post-capillary PH, is the most common etiology of PH. Left heart disease due to systolic dysfunction or heart failure with preserved ejection fraction, valvular heart disease, and left atrial myopathy due to atrial fibrillation are causes of post-capillary PH. Elevated left-sided filling pressures cause pulmonary venous congestion due to backward transmission of pressures and post-capillary PH. In advanced left-sided heart disease or valvular heart disease, chronic uncontrolled venous congestion may lead to remodeling of the pulmonary arterial system, causing combined pre-capillary and post-capillary PH. The hemodynamic definition of post-capillary PH includes a mean pulmonary arterial pressure > 20 mmHg, pulmonary vascular resistance < 3 Wood units, and pulmonary capillary wedge pressure > 15 mmHg. Echocardiography is important in the identification and management of the underlying cause of post-capillary PH. Management of post-capillary PH is focused on the treatment of the underlying condition. Strategies are geared towards pharmacotherapy and guideline-directed medical therapy for heart failure, surgical or percutaneous management of valvular disorders, and control of modifiable risk factors and comorbid conditions. Referral to centers with advanced heart and pulmonary teams has shown to improve morbidity and mortality. There is emerging interest in the use of targeted agents classically used in pulmonary arterial hypertension, but current data remain limited and conflicting. This review aims to serve as a comprehensive summary of postcapillary PH and its etiologies, pathophysiology, diagnosis, and management, particularly as it pertains to advanced heart failure.
引用
收藏
页数:13
相关论文
共 50 条
  • [41] PULMONARY HYPERTENSION IN IDIOPATHIC PULMONARY FIBROSIS: A REVIEW
    Corte, T. J.
    Wort, S. J.
    Wells, A. U.
    SARCOIDOSIS VASCULITIS AND DIFFUSE LUNG DISEASES, 2009, 26 (01) : 7 - 19
  • [42] Pulmonary Hypertension in Left Heart Disease
    Reddy, Yogesh N., V
    Borlaug, Barry A.
    CLINICS IN CHEST MEDICINE, 2021, 42 (01) : 39 - 58
  • [43] Pitx2c-Conditional Knockout Mice May Become a Useful Model to Elucidate the Pathogenesis of Post-Capillary Pulmonary Hypertension
    Seya, Daiki
    Inoue, Takahiro
    Baba, Sunsuke
    Akaike, Toru
    Minamisawa, Susumu
    CIRCULATION, 2023, 148
  • [44] Clinical and Biological Insights Into Combined Post- and Pre-Capillary Pulmonary Hypertension
    Assad, Tufik R.
    Hemnes, Anna R.
    Larkin, Emma K.
    Glazer, Andrew M.
    Xu, Meng
    Wells, Quinn S.
    Farber-Eger, Eric H.
    Sheng, Quanhu
    Shyr, Yu
    Harrell, Frank E.
    Newman, John H.
    Brittain, Evan L.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2016, 68 (23) : 2525 - 2536
  • [45] Pulmonary arterial capacitance in patients with heart failure and reactive pulmonary hypertension
    Dragu, Robert
    Rispler, Shmuel
    Habib, Manhal
    Sholy, Haitham
    Hammerman, Haim
    Galie, Nazzareno
    Aronson, Doron
    EUROPEAN JOURNAL OF HEART FAILURE, 2015, 17 (01) : 74 - 80
  • [46] Left ventricular heart failure and pulmonary hypertension
    Rosenkranz, Stephan
    Gibbs, J. Simon R.
    Wachter, Rolf
    De Marco, Teresa
    Vonk-Noordegraaf, Anton
    Vachiery, Jean-Luc
    EUROPEAN HEART JOURNAL, 2016, 37 (12) : 942 - +
  • [47] Role of pulmonary arterial capacitance in predicting mortality in patients with pulmonary hypertension: A systematic review and meta-analysis
    Rajdev, Kartikeya
    Lahan, Shubham
    Wichman, Tammy
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2021, 333 : 202 - 209
  • [48] Pulmonary Artery Denervation Significantly Increases 6-Min Walk Distance for Patients With Combined Pre- and Post-Capillary Pulmonary Hypertension Associated With Left Heart Failure The PADN-5 Study
    Zhang, Hang
    Zhang, Juan
    Chen, Mengxuan
    Xie, Du-Jiang
    Kan, Jing
    Yu, Wande
    Li, Xiao-Bo
    Xu, Tian
    Gu, Yue
    Dong, Jianzeng
    Gu, Hong
    Han, Yaling
    Chen, Shao-Liang
    JACC-CARDIOVASCULAR INTERVENTIONS, 2019, 12 (03) : 274 - 284
  • [49] Pulmonary hypertension in sarcoidosis: A review
    Corte, Tamera J.
    Wells, Athol U.
    Nicholson, Andrew G.
    Hansell, David M.
    wort, Stephen J.
    RESPIROLOGY, 2011, 16 (01) : 69 - 77
  • [50] Pulmonary Hypertension in Idiopathic Pulmonary Fibrosis: A Review
    Pitsiou, Georgia
    Papakosta, Despina
    Bouros, Demosthenes
    RESPIRATION, 2011, 82 (03) : 294 - 304